SPOTLIGHT -
Follow-up trials for accelerated approval drugs often miss FDA deadline
Data suggest confirmatory trials conducted for drugs granted accelerated approval by the FDA have taken a median 3.5 years to complete since 2012.
VP-102 resubmitted to FDA for molluscum contagiosum approval
After addressing a 2021 CRL, Verrica Pharmaceuticals vies for the agent to become the first drug approved to treat the common skin infection.
Pediatric cannabis poisoning hospitalizations spiked in Canada after edible legalization
A cross-sectional study showed cannabis ingestion has been the cause of 1 in every 3 pediatric poisoning hospitalizations in provinces that sell edibles.
COVID-19, flu coinfection in children can require more respiratory ventilation use
New surveillance data from the 2021-22 influenza show the impact of coinfection among younger patients.
Early childhood sleep intervention is more cost-effective for lower socioeconomic groups
An economic analysis of a clinical sleep intervention suggests it may provide a step toward improved health equity.
Apremilast may significantly, safely benefit severe pediatric psoriasis
New 16-week data from the SPROUT trial show the PDE4 inhibitor may be highly efficacious in children and adolescents.
Tralokinumab benefits adolescent eczema patient-reported outcomes at 16 weeks
New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.
Novavax nears maternal immunization results for RSV vaccine
